Takeda Pharmaceutical Company’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Hold |
6,724,000
| – | – | 68.43% | 1 |
|
|
2025
Q1 | $9.75M | Hold |
6,724,000
| – | – | 60.21% | 1 |
|
|
2024
Q4 | $13.9M | Hold |
6,724,000
| – | – | 52.4% | 1 |
|
|
2024
Q3 | $11.8M | Hold |
6,724,000
| – | – | 31.18% | 1 |
|
|
2024
Q2 | $97.2M | Hold |
6,724,000
| – | – | 41.85% | 2 |
|
|
2024
Q1 | $112M | Hold |
6,724,000
| – | – | 38.69% | 1 |
|
|
2023
Q4 | $108M | Buy |
+6,724,000
| New | +$108M | 32.95% | 1 |
|